Impact of new therapeutics for hepatitis C virus infection in incarcerated populations.

@article{Spaulding2013ImpactON,
  title={Impact of new therapeutics for hepatitis C virus infection in incarcerated populations.},
  author={Anne S Spaulding and Arthur Y. Kim and Amy Jo Harzke and J Cherry Sullivan and Benjamin P Linas and Arthur Brewer and Jeff Dickert and Barbara Hedgis McGovern and Lara B Strick and Robert L. Trestman and Warren J. Ferguson},
  journal={Topics in antiviral medicine},
  year={2013},
  volume={21 1},
  pages={27-35}
}
Inmate populations bear a disproportionate share of the burden of hepatitis C virus (HCV) infection. With more than 90% of prisoners released back to their communities within a few years of sentencing, incarceration can be viewed as an opportunity to provide HCV screening and therapeutic interventions to benefit the individual, reduce the costs of HCV management to the health care system from a societal perspective, and improve overall public health. Although optimal medical management of HCV… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 7 times over the past 90 days. VIEW TWEETS